Baylor University Medical Center
Dermatology residency · Dallas, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Baylor University Medical Center's research in dermatology, which the program shares with other departments and affiliated hospitals.
About Baylor University Medical Centerinstitution-wide dermatology research
Dermatology publications from Baylor University Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
15
works per year
40th of 58 dermatology residency programs
+110.5%
2-year growth
3rd of 58 dermatology residency programs
23.5%
in top 10% of field (works before 2025)
10th of 50 dermatology residency programs
55.9%
cited above world average
1st of 50 dermatology residency programs
Works per year · * 2026 so far
Dermatology · 76
Dermatology research topics at Baylor University Medical Center
Papers in the window; each links to the list on OpenAlex.
- Cancer and Skin Lesions 18
- Dermatology and Skin Diseases 14
- Acne and Rosacea Treatments and Effects 13
- Hidradenitis Suppurativa and Treatments 12
- Facial Rejuvenation and Surgery Techniques 5
- Skin Diseases and Diabetes 5
- Dermatologic Treatments and Research 4
- Cutaneous lymphoproliferative disorders research 3
Most cited at Baylor University Medical Center since 2024
All dermatology papers there on OpenAlex
- Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and ChildrenEric Lawrence Simpson et al. · JAMA Dermatology · 2024 · PubMed · cited 71
- Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentationAndrew F Alexis et al. · International Journal of Dermatology · 2024 · PubMed · cited 27
- Low‐dose isotretinoin for the management of rosacea: A systematic review and meta‐analysisAliyah King et al. · Journal of the European Academy of Dermatology and Venereology · 2024 · PubMed · cited 16
- Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable StudyAndrew F Alexis et al. · American Journal of Clinical Dermatology · 2025 · PubMed · cited 11
- Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other RetinoidsNaiem Tony Issa et al. · Dermatology and Therapy · 2025 · PubMed · cited 10
- The lip flip: a systematic review of botulinum toxin lip augmentationChase Andrew Pitchford et al. · Archives of Dermatological Research · 2025 · PubMed · cited 7
- Surgical treatment of pilomatrix carcinoma: a systematic reviewHannah R. Riva et al. · International Journal of Dermatology · 2024 · PubMed · cited 7
- Glucagon-like peptide-1 receptor agonist use is associated with increased rates of acne vulgaris diagnosis in nondiabetic obese women but not men: A retrospective cohort studySeo Won Cho et al. · Journal of the American Academy of Dermatology · 2025 · PubMed · cited 6
- Facial nodules following filler injections after initiating compounded tirzepatide useLuke Moore et al. · JAAD Case Reports · 2026 · PubMed · cited 5
- Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase 3b/4 Study (LEVEL UP)Christopher G. Bunick et al. · American Journal of Clinical Dermatology · 2026 · PubMed · cited 5